# Phathom Pharmaceuticals, Inc.: Form 8-K, filed Aug 4, 2022

- Company: [Phathom Pharmaceuticals, Inc.](/companies/phat.md) (CIK 1783183)
- Form: 8-K
- Filed: 2022-08-04
- Accepted by EDGAR: Aug 4, 2022, 16:06 ET
- Period: 2022-08-01
- Accession: 0001193125-22-212499
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1783183/000119312522212499/d385505d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1783183/000119312522212499/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1783183/000119312522212499/d385505d8k.htm

Filed Aug 4, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-212499. Last ingested by Listed: Nov 11, 2026, 03:04 ET. No prices; not investment advice.
